NCT04708730已完成不适用
Improving Neuroprotective Strategy for Ischemic Stroke After Thrombectomy Followed by DELP (INSIST-DELP): a Prospective, Random, Open-label, Blind-endpoint, Multi-centre Study
General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年8月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Proportion of patients with modified Rankin Score 0 to 2
研究概览
简要总结
Delipid Extracorporeal Lipoprotein filter from Plasma (DELP) has been found to improve neurological function and life ability of AIS patients and approved for the treatment of AIS by China Food and Drug Administration (CFDA). Our recent study imply that the neuroprotective effect of DELP involved multiple neuroprotective mechanism such as anti-inflammation, free radical scavenging, and decreasing MMP-9. Based on the multiple mechanisms, DELP was used to investigate the effect on acute ischemic stroke receiving endovascular treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥18 years;
- •acute anterior circulatory cerebral infarction with large vessel occlusion;
- •NIHSS≥6 before endovascular treatment;
- •good recanalization (TICI 2b-3);
- •time from onset to groin puncture is less than 8 hours;
- •time from recanalization to DELP is less than 2 hours;
- •Premorbid mRS 0 or 1;
- •Signed informed consent.
排除标准
- •poor recanalization (TICI 1-2a);
- •Coagulation disorders, systematic hemorrhagic tendency, thrombocytopenia （ <100000/mm3;
- •Severe hepatic or renal dysfunction, increase in ALT or AST (more than 2 times of upper limit of normal value), increase in serum creatinine (more than 1.5 times of upper limit of normal value) or requiring dialysis;
- •Severe hypertension (systolic blood pressure over 200mmHg or diastolic blood pressure over 110 mmHg);
- •Previous allergy to heparin or calcium;
- •hypoproteinemia;
- •Unsuitable for this clinical studies assessed by researcher.
结局指标
主要结局
Proportion of patients with modified Rankin Score 0 to 2
时间窗: Day 90
次要结局
- Proportion of patients with modified Rankin Score 0 to 1(Day 90)
- Changes in national institutes of health stroke scale (NIHSS)(7 days)
- Changes in cerebral infarct volume(48 hours)
- the occurence of stroke or other cardiovascular events(Day 90)
- the occurence of infections post stroke(Day 14)
- Proportion of symptomatic intracranial hemorrhage (sICH)(48 hours)
- Proportion of intraparenchymal hemorrhage (PH1 and PH2)(48 hours)
- the occurence of death due to any cause(Day 90)
研究者
Hui-Sheng Chen
Head of Neurology
General Hospital of Shenyang Military Region
研究点 (1)
Loading locations...
相似试验
暂停
不适用
Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic StrokeHemorrhagic StrokeNCT05128513General Hospital of Shenyang Military Region356
终止
2 期
DELP for Acute Hemorrhagic StrokeCerebral HemorrhageNCT04708990General Hospital of Shenyang Military Region10
招募中
不适用
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion StrokeIschemic StrokeSmall Vessel Cerebrovascular DiseaseCholesterol, LDLSecondary PreventionCardiovascular DiseasesNCT06649240Seoul National University Hospital4,016
已完成
2 期
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)Multiple Sclerosis, Chronic ProgressiveNCT01188811VA Office of Research and Development54
已完成
不适用
Study of the Effects of the Non-invasive Trigeminal Nerve Stimulation on Ischemic Stroke PatientsAcute Ischemic StrokeNCT06540417Xidian University60